Does Ozempic Lower Testosterone?

Ozempic (semaglutide) has become one of the most widely prescribed medications for type 2 diabetes and weight management. As millions of men begin using it, the question has risen to the forefront of men’s health: does Ozempic lower testosterone? The concern is understandable — testosterone is central to male energy, body composition, mood, libido, and overall vitality.

Here is the honest answer: we do not yet know whether semaglutide directly affects testosterone independent of weight loss. The research on that specific question is preliminary. What is clearer is that meaningful weight loss in men with obesity-driven low testosterone often improves testosterone levels — primarily through reduced aromatase activity in fat tissue. So the question of whether Ozempic itself raises testosterone is partly the wrong question. The better question is what happens to body composition and hormonal health for men who need both testosterone replacement therapy and semaglutide, which is the situation most of our patients are actually in.

What we see in our practice: men on TRT who add semaglutide do not lose muscle the way patients on semaglutide alone often do. Some of our patients actually build muscle on this combination — fat comes off, lean mass is protected by adequate testosterone and resistance training, and the weight loss-driven testosterone improvement compounds. Most men who come to us with low testosterone are already candidates for TRT before they consider a GLP-1, so the practical question is not whether GLP-1s alone fix the hormonal picture — it is how to optimize body composition for men who already need both.

This article covers what the research does and does not show on Ozempic and testosterone, why the obesity-testosterone connection matters, and how we approach the combination of TRT and semaglutide in our practice.

How Ozempic Works

Ozempic is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics the action of a naturally occurring gut hormone that your body releases after eating. When activated, the GLP-1 receptor pathway produces several effects:

• Increased insulin secretion in response to elevated blood sugar (glucose-dependent, reducing hypoglycemia risk)
• Suppressed glucagon release from the pancreas, which helps lower blood sugar
• Slowed gastric emptying — food remains in the stomach longer, promoting prolonged satiety
• Central appetite suppression — GLP-1 acts on receptors in the hypothalamus and brainstem to reduce hunger signals

These combined effects produce significant weight loss and improved metabolic health. The STEP 1 trial demonstrated average weight loss of 14.9% of body weight over 68 weeks with semaglutide 2.4 mg weekly, compared to 2.4% with placebo (Wilding et al., New England Journal of Medicine, 2021).

Ozempic is administered as a once-weekly subcutaneous injection, with doses typically escalated from 0.25 mg to a maintenance dose of 0.5 mg, 1 mg, or 2 mg for diabetes management. Wegovy, the weight management formulation, reaches a maximum dose of 2.4 mg weekly.

Understanding the Obesity-Testosterone Connection

To understand why Ozempic might actually improve testosterone, you first need to understand why obesity lowers it. The relationship between excess body fat and low testosterone is well-established, bidirectional, and driven by several physiological mechanisms.

Aromatase and Estrogen Conversion

Adipose tissue (body fat) contains high concentrations of the enzyme aromatase, which converts testosterone into estradiol (a form of estrogen). The more body fat a man carries, the more aromatase activity occurs, and the more testosterone is converted to estrogen.

A landmark study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that total testosterone levels decrease by approximately 2.4% for each unit increase in BMI (Travison et al., 2007). This means a man with a BMI of 35 may have testosterone levels 25–30% lower than an otherwise identical man with a BMI of 25.

Insulin Resistance and SHBG

Obesity typically produces insulin resistance, which has a direct negative effect on testosterone through sex hormone-binding globulin (SHBG). Insulin resistance lowers SHBG production by the liver, and SHBG plays a complex role in testosterone availability. While lower SHBG increases free testosterone in the short term, chronic insulin resistance and hyperinsulinemia are associated with overall suppression of the hypothalamic-pituitary-gonadal (HPG) axis.

Research by Grossmann et al. published in Clinical Endocrinology (2010) established that insulin resistance and hyperinsulinemia independently suppress luteinizing hormone (LH) pulsatility, which in turn reduces testicular testosterone production.

Chronic Inflammation

Obesity is characterized by chronic low-grade systemic inflammation. Elevated levels of inflammatory cytokines — including TNF-alpha, IL-6, and C-reactive protein — directly impair Leydig cell function in the testes, reducing testosterone synthesis. A study in The Journal of Clinical Investigation showed that inflammatory cytokines suppress steroidogenic enzyme expression in testicular cells (Hong et al., 2004).

The Hypogonadal-Obesity Cycle

These mechanisms create a self-reinforcing cycle: obesity lowers testosterone, and low testosterone promotes further fat accumulation (particularly visceral fat), insulin resistance, and inflammation — which further suppresses testosterone. This cycle, described in the medical literature as the hypogonadal-obesity cycle (Cohen, 1999), can be difficult to break without intervention.

What the Research Says About Ozempic and Testosterone

Preliminary Conference Data

Preliminary data presented at the Endocrine Society’s 2025 annual meeting (ENDO 2025) suggested testosterone improvements in men with type 2 diabetes and obesity on GLP-1 receptor agonists, with the largest improvements in men who started with the lowest baseline testosterone and the highest BMI. The reported pattern aligned with what we already know about weight loss and testosterone — the improvements correlated with the degree of weight loss and the improvements in insulin sensitivity.

Conference presentations are preliminary by definition. The findings have not yet been published in peer-reviewed form and the specific effect size estimates may shift before final publication. We mention them here because the direction of the data is consistent with the broader weight loss / testosterone literature, not because they constitute settled evidence on their own.

Weight Loss and Testosterone Recovery

Multiple studies have established that weight loss — regardless of method — improves testosterone in obese men:

• A meta-analysis published in European Journal of Endocrinology found that each kilogram of weight loss was associated with a 0.58 nmol/L (approximately 16.7 ng/dL) increase in total testosterone (Corona et al., 2013)
• The Massachusetts Male Aging Study demonstrated that a 4–5 point BMI decrease was associated with a testosterone increase comparable to 10 years of age-related decline being reversed (Travison et al., 2007)
• A randomized controlled trial published in JAMA Internal Medicine showed that an intensive lifestyle intervention producing 10% weight loss increased total testosterone by 2.9 nmol/L (approximately 84 ng/dL) compared to controls over one year (Niskanen et al., 2004)

Since Ozempic produces average weight loss of 10–15% of body weight, the expected testosterone improvement is clinically meaningful for most obese men.

Semaglutide- and Liraglutide-Specific Research

The published research specifically examining GLP-1 medications and testosterone in men is limited and early. Small studies of liraglutide in obese men with hypogonadism have shown weight loss-driven testosterone improvements, with magnitude that varies substantially between individuals. Semaglutide-specific data on testosterone outcomes in men is even more sparse — most of what we know comes from inference based on the broader weight loss / testosterone literature plus emerging case series.

The honest framing: this is not yet settled evidence. The mechanism is plausible (weight loss → reduced aromatase → less testosterone-to-estrogen conversion → higher net testosterone), the broader weight-loss-and-testosterone literature is consistent, and the early GLP-1-specific data points in the same direction. But the trials needed to definitively establish a direct semaglutide-on-testosterone effect have not yet been done.

How Semaglutide May Improve Testosterone: The Three Mechanisms

Mechanism 1: Reduced Aromatase Activity Through Fat Loss

As men lose body fat on Ozempic, the total amount of aromatase enzyme in their body decreases. Less aromatase means less testosterone is converted to estrogen, allowing testosterone levels to rise. This is likely the most significant mechanism by which Ozempic improves testosterone.

Clinical studies have confirmed that weight loss-associated testosterone improvements are closely correlated with reductions in total body fat mass and, particularly, visceral adipose tissue (Grossmann, 2014). Visceral fat is metabolically more active than subcutaneous fat and contains higher aromatase concentrations.

Mechanism 2: Improved Insulin Sensitivity

Ozempic directly improves insulin sensitivity through GLP-1 receptor activation, independent of weight loss. Better insulin sensitivity reduces hyperinsulinemia, which in turn:

• Restores normal LH pulsatility from the pituitary gland
• Increases SHBG production from the liver
• Reduces the suppressive effect of insulin on testicular testosterone production

A study in Fertility and Sterility demonstrated that improving insulin sensitivity (whether through weight loss, metformin, or other interventions) consistently increases testosterone levels in men with metabolic syndrome (Grossmann et al., 2010).

Mechanism 3: Reduced Systemic Inflammation

Weight loss with Ozempic reduces circulating levels of inflammatory cytokines (TNF-alpha, IL-6, CRP). Lower inflammation removes a direct suppressive influence on Leydig cell function and testosterone biosynthesis.

The SELECT cardiovascular outcomes trial demonstrated that semaglutide significantly reduced high-sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation, by 37.8% compared to placebo over the study period (Lincoff et al., NEJM, 2023). This anti-inflammatory effect likely contributes to hormonal improvements.

Reports of Erectile Dysfunction: What to Know

Despite the positive overall picture, some men have reported erectile dysfunction (ED) after starting Ozempic. This has understandably contributed to concerns about testosterone. Several factors may explain these reports:

Rapid Weight Loss and Hormonal Flux

Rapid weight loss can temporarily disrupt hormonal equilibrium. As the body adapts to a new metabolic state, transient changes in estrogen-testosterone balance, SHBG levels, and hypothalamic-pituitary signaling may occur. These disruptions are typically temporary and resolve as weight stabilizes.

Nutritional Deficiencies

Significant caloric restriction — whether from Ozempic-induced appetite suppression or intentional dieting — can lead to deficiencies in nutrients critical for sexual function, including zinc, magnesium, vitamin D, and essential fatty acids. Ensuring adequate nutrition despite reduced appetite is important.

Psychological and Relationship Factors

Weight loss often coincides with changes in body image, self-perception, and relationship dynamics. Psychological factors remain the most common cause of erectile dysfunction in men under 40 and a significant contributor at all ages.

Fatigue and Energy Changes

Some men experience fatigue during the dose escalation phase of Ozempic, which can affect libido and sexual performance. This typically improves as the body adapts to the medication.

Underlying Vascular Disease

Many men starting Ozempic have pre-existing cardiovascular and vascular conditions that contribute to ED independently of the medication. It is important not to attribute ED to Ozempic without a thorough evaluation of other potential causes.

Who Benefits Most from Ozempic’s Testosterone Effects?

Based on the available evidence, the men most likely to see testosterone improvements on Ozempic include:

• Men with obesity (BMI 30+) — the greater the degree of excess body fat, the more aromatase is present, and the more room for improvement with weight loss
• Men with type 2 diabetes — insulin resistance is a major driver of low testosterone, and Ozempic directly improves insulin sensitivity
• Men with metabolic syndrome — the cluster of conditions (abdominal obesity, dyslipidemia, hypertension, insulin resistance) is strongly associated with hypogonadism
• Men with borderline-low testosterone (200–400 ng/dL) — weight loss may push levels back into the normal range without requiring testosterone replacement therapy

Men who are less likely to see testosterone benefits include:

• Lean men without metabolic dysfunction — if obesity is not driving low testosterone, removing it through weight loss will not help
• Men with primary hypogonadism — testicular failure requires direct testosterone replacement regardless of weight
• Men with pituitary disorders — hypothalamic or pituitary causes of low testosterone will not be corrected by weight loss alone

Monitoring Testosterone While on Ozempic

Men using Ozempic should follow a structured monitoring protocol to track hormonal health:

Before Starting Treatment

• Total testosterone (morning draw, fasting)
• Free testosterone
• SHBG (sex hormone-binding globulin)
• Estradiol
• LH (luteinizing hormone) and FSH (follicle-stimulating hormone)
• Complete metabolic panel including fasting glucose, HbA1c, and lipids
• PSA (prostate-specific antigen) for baseline

During Treatment (Every 3–6 Months)

• Repeat testosterone panel (total, free, SHBG, estradiol)
• Metabolic markers (HbA1c, fasting glucose, lipids)
• Complete blood count
• Assessment of symptoms (energy, libido, mood, sexual function)
• Body composition evaluation

Red Flags to Discuss with Your Physician

• Persistent fatigue despite adequate sleep and nutrition
• Declining libido or onset of erectile dysfunction
• Mood changes (depression, irritability, loss of motivation)
• Loss of lean muscle mass despite resistance training
• Testosterone levels declining below baseline during treatment

Combining Ozempic with Testosterone Optimization

For men whose testosterone does not adequately improve with weight loss alone, or who begin treatment with clinically low levels, additional hormonal interventions may be warranted:

Testosterone Replacement Therapy (TRT)

TRT alongside Ozempic is the configuration most of our patients are actually in. Pairing testosterone therapy with semaglutide addresses metabolic health and hormonal deficiency simultaneously, and it has a body composition advantage that semaglutide alone does not: in our practice, men on TRT who add semaglutide tend to lose fat without losing muscle the way patients on semaglutide alone often do. With adequate protein intake and resistance training, some of our patients build muscle on this combination — fat comes off, lean mass is protected by adequate testosterone, and the visceral fat reduction further supports hormonal health.

Available TRT forms include injectable testosterone cypionate or enanthate, topical gels or creams, and subcutaneous pellets. The right form depends on your labs, lifestyle, and preferences — and the dosing should be calibrated against the body composition changes happening on semaglutide concurrently, not just standard TRT targets.

Clomiphene Citrate

For men who wish to preserve fertility (which TRT can compromise), clomiphene citrate stimulates the body’s own testosterone production by increasing LH secretion. It can be used alongside Ozempic as a less suppressive alternative to exogenous testosterone.

Enclomiphene

Enclomiphene, the trans-isomer of clomiphene, offers similar LH-stimulating effects with potentially fewer estrogenic side effects. It is available through compounding pharmacies and is sometimes preferred for younger men seeking testosterone optimization without fertility compromise.

Lifestyle Optimization

Regardless of medication choices, the following lifestyle factors significantly impact testosterone:

• Resistance training — particularly compound movements (squats, deadlifts, bench press) stimulate acute testosterone elevations and support long-term hormonal health
• Adequate sleep — testosterone production peaks during deep sleep. Men sleeping less than 7 hours nightly show significantly lower testosterone levels (Leproult and Van Cauter, JAMA, 2011)
• Stress management — chronic stress elevates cortisol, which directly suppresses testosterone production
• Nutritional adequacy — zinc, vitamin D, magnesium, and healthy fats are essential for testosterone biosynthesis

Practical Recommendations for Men on Ozempic

1. Get baseline labs before starting — know your testosterone, metabolic markers, and body composition before treatment begins
2. Prioritize protein — aim for 0.7–1.0 grams per pound of ideal body weight daily to preserve muscle mass
3. Lift weights regularly — resistance training 3–4 times per week protects muscle and supports testosterone
4. Monitor symptoms — track energy, libido, mood, and sexual function throughout treatment
5. Recheck labs every 3–6 months — testosterone improvements typically become measurable by 3–6 months of sustained weight loss
6. Do not assume ED is from Ozempic — get a thorough evaluation of all potential causes before attributing sexual dysfunction to the medication
7. Consider combination therapy if needed — if testosterone remains low despite weight loss, discuss TRT or other hormonal interventions with your physician

How Rewind Anti-Aging of Miami Can Help

At Rewind Anti-Aging of Miami, we specialize in the intersection of metabolic health and hormonal optimization. Our approach recognizes that weight management and testosterone levels are deeply interconnected, and we build treatment plans that address both simultaneously.

Our men’s health programs include comprehensive hormonal and metabolic laboratory panels, personalized semaglutide dosing protocols with careful titration, testosterone monitoring with intervention when clinically indicated, access to TRT, clomiphene, enclomiphene, and other hormonal therapies, nutritional guidance focused on preserving muscle mass and supporting hormonal health, and ongoing medical oversight with regular progress assessments.

Whether Ozempic alone is sufficient to improve your testosterone, or whether additional hormonal support is needed, our team develops a plan built around your labs, symptoms, and goals. Book a consultation to discuss how we can help you optimize both your metabolic and hormonal health.

Conclusion

Current evidence does not show Ozempic directly lowering testosterone in men. The research on whether semaglutide independently raises testosterone — separate from the weight loss it produces — is still preliminary and the trials needed to settle that question have not been done. What the broader weight loss literature does establish, and what we see in our practice, is that meaningful weight loss in men with obesity-driven low testosterone often improves testosterone — primarily through reduced aromatase activity in fat tissue.

The more practical question for most men considering both treatments is not whether GLP-1s alone fix the hormonal picture. It is how to combine TRT and semaglutide safely so that fat loss does not come at the cost of muscle mass. In our experience, men on TRT who add semaglutide often preserve — and sometimes build — muscle while losing fat, in a way that patients on semaglutide alone typically do not. The combination is where the practical value lies, not the GLP-1 alone.

Men whose low testosterone has non-obesity causes (primary hypogonadism, pituitary issues, age-related decline at a normal BMI) generally will not see testosterone improvement from weight loss alone, regardless of how the weight loss is achieved. That is why the right starting point is comprehensive lab work and an honest assessment of what is actually driving your testosterone level.

Related Articles

• Tirzepatide and Testosterone: What You Need to Know
• Does Ozempic Lower Cholesterol?
• Low Testosterone and Weight Gain

---

Concerned about testosterone and weight loss? Rewind Anti-Aging of Miami offers personalized semaglutide therapy alongside testosterone therapy with comprehensive hormonal monitoring. Schedule a consultation →

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Medications should only be used under the supervision of a qualified healthcare provider. Individual results vary. Always consult with your physician before starting any new medication or making changes to your treatment plan.